ArticleCancer diagnosis & prognosis

Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma.

Ryo Kurashina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.